Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome

详细信息    查看全文

• 作者：Chen Zhang ; Zhiguo Wu ; Wu Hong ; Zuowei Wang ; Daihui Peng ; Jun Chen ; Chengmei Yuan ; Shunying Yu ; Lin Xu ; Yiru Fang
• 关键词：B-cell/lymphoma 2 ; Major depressive disorder ; Treatment-resistant depression ; Association
• 刊名：Journal of Affective Disorders
• 出版年：February, 2014
• 年：2014
• 卷：155
• 期：Complete
• 页码：288-294
• 全文大小：318 K

文摘

Background

Our recent work indicated that low-expression of the anti-apoptotic protein B-cell/lymphoma 2 (Bcl-2) mRNA was observed among untreated major depressive disorder (MDD) patients, and the subsequent altered level of Bcl-2 was found to be close to the antidepressant treatment outcome. The primary aim of this present study was to examine whether a particular gene, encoding Bcl-2 (BCL2) confers risk to MDD, and likewise to investigate whether this gene acts as an indicator of antidepressant treatment outcome.

Methods

We enrolled 178 treatment-resistant depression (TRD) and 612 non-treatment-resistant depression (NTRD) patients as well as 725 healthy controls. In total, three selected tagging SNPs (tagSNPs) of BCL2 (rs2279115, rs1801018 and rs1564483) were genotyped to test for possible association. Using TaqMan relative quantitative real-time polymerase chain reaction (PCR), we analyzed leukocytic expression of BCL2 mRNA in 47 healthy subjects.

Results

Of the three SNPs, we observed no significant differences in genotype and allele frequencies between the MDD and control groups as well as between the TRD and NTRD groups. However, we found a significant association between the rs2279115C allele and TRD in males (corrected P=0.048) but not in females. Further real-time quantitative PCR analysis in healthy subjects revealed that the rs2279115 polymorphism significantly influenced BCL2 mRNA expression (P=0.03).

Limitations

This is a preliminary investigation with relatively small sample size and cross-sectional design.

Conclusions

These initial findings strengthen the hypothesis that BCL2 may play an important role in mediating the outcome of antidepressant treatment, a result that may further be confirmed by future genetic studies from large-scale populations that can overcome the limited sample size of this preliminary finding.